CME credits: 1.00

Valid until: 23-06-2024

Claim your CME credit at https://reachmd.com/programs/cme/lessening-glaucoma-treatment-burden-sustained-release-therapies-part-2/15195/

First-line treatment for glaucoma is typically pharmacologic and aimed at lowering intraocular pressure, which is the only modifiable risk factor to date. However, successful treatment with traditional topical glaucoma medications may be limited by their well-known barriers of adverse effects and poor patient adherence to drop instillation. Tune in to hear Dr. Qi Cui and Dr. Davinder Grover discuss the novel pharmacological therapies and minimally invasive glaucoma surgery procedures that can lower treatment burden and increase compliance.